The calcium-binding proteins of the human S100A7/A15 (hS100A7/A15) subfamily are differentially expressed in normal and pathological epidermis. The hS100A7 (psoriasin) and S100A15 reside in a chromosomal cluster of highly similar paralogs. To exploit the power of mouse models for determining functions of gene products, the corresponding S100A7/A15 ortholog was cloned and examined in murine skin. The single mouse S100A15 (mS100A15) gene encodes a protein of 104 amino acids with a predicted molecular weight of 12,870 Da and two EF-hand calcium binding sites. Using gene-specific primers and specific antibodies, expression of mS100A15 in both skin and isolated keratinocytes is confined to differentiating granular and cornified epidermal cells. Immunoblotting of epidermal extracts revealed a series of high molecular weight bands that are also recognized by an antibody for transglutaminase-mediated protein crosslinks. mS100A15 expression is upregulated in cultured keratinocytes induced to differentiate by calcium or phorbol esters. Maximal induction occurs concordantly with expression of late differentiation markers. Induction is enhanced in keratinocytes overexpressing protein kinase Ca and is dependent on activator protein-1 transcription factors. The regulation, expression pattern and crosslinking of mS100A15 are consistent with the characteristics of the human orthologs, providing a valid surrogate model to study changes in these proteins associated with cutaneous pathologies.
INTRODUCTION S100 proteins are small, calcium-binding proteins constituting the largest, multigenic family of calcium-binding EF-hand proteins (Schafer and Heizmann, 1996; Donato, 2003) . Many S100 proteins show distinct tissue and cell-type-specific expression patterns indicating local specification. In addition, they undergo conformational changes in response to calcium that contribute to their functional diversification. The proteins of the S100A7/A15 family are of major interest because of their differential expression and putative functional role in epidermal cell maturation, tumorigenesis, and inflammation (Broome et al., 2003; Eckert et al., 2004; Emberley et al., 2004; Marenholz et al., 2004) . The human calcium-binding protein S100A7 was first identified as a protein upregulated in inflamed hyperplastic psoriatic skin (Madsen et al., 1991) . The highly homologous human S100A15 (hS100A15) was recently identified in psoriasis and found to also be upregulated in lesional skin (Wolf et al., 2003) . Genomic analysis of the S100A7 and S100A15 encoding chromosomal regions reveals that both must have evolved by gene duplications during primate evolution, forming an innate subfamily in man (Kulski et al., 2003) . The coexpression of the hS100A7 and hS100A15 in psoriasis suggests that both proteins participate in keratinocyte maturation, proliferation and/or skin inflammation. However, the existence of two highly similar paralogs (490% identity) sets certain limits in discriminating between them when coregulated. Furthermore, little is known about the functional role of the S100A7/A15 proteins in cutaneous pathology, yet they are frequently dysregulated in a variety of pathological conditions including cutaneous cancer. In order to establish a valid model for understanding the functions of S100A7/A15 in the epidermis, we initiated a study to characterize the murine ortholog of the hS100A7/A15 subfamily and compare its properties to those known for the human genes and proteins.
RESULTS
Cloning and characterization of the mouse S100A15
Sequence alignment of the hS100A15 cDNA to a mouse genomic contig (accession no.: NW_000191.1; now UCSC mm6) identified three exon-corresponding matches. Appropriate gene-spanning primers were designed, which allowed PCR amplifying of the predicted mouse transcript of cDNAderived from adult normal murine skin.
The mouse S100A15 (mS100A15) transcript aligned to a genomic region of 1,329 nucleotide (nt) in total and is organized in three exons and two introns with exon/intron boundaries following the GT-AG rule ( Figure S1a ). Exon 1 is untranslated, the translation is initiated within exon 2 and terminated in exon 3 spanning an open reading frame of 327 nt (nt 111-437) . The open reading frame translates into a characteristic S100 protein sequence of 109 amino acids (aa), with a calculated molecular weight of 12,870 Da and a predicted pI of 6.18. The deduced mS100A15 protein sequence contains two helix-loop-helix motifs corresponding to two EF-hand calcium binding sites, which both are typical for S100 proteins ( Figure S1b ): a variant S100-specific motif at the N-terminus (aa 06-49) and a conserved, canonical site at the C-terminus (aa 57-85). Furthermore, potential transglutaminase-reactive glutamine (Q 12, 54, 72, 92, 96 ) and lysine residues (K 27, 36, 84, 87 ) are found throughout the entire protein sequence. The genomic and the mRNA S100A15 sequence entries are available under GenBank accession nos.: AY465109-AY465110.
In mice, hybridization of a specific mS100A15 probe to digested genomic DNA led to a restriction pattern ( Figure  S2a ) that was reconstructed as a single genomic match ( Figure S2b ). Blast alignment of the sequenced cDNA also mapped the mS100A15 to a single genomic region on chromosome 3qF1 (Figure 1a ) within the murine equivalent of the human epidermal differentiation complex. The positioning and directionality of most of the S100 genes is highly conserved among the two species. However, multiple copies of genes similar to S100A15 are found in human that vary in orientation (Figure 1a ) participating in a cluster of highly similar paralogs forming an innate S100A7/A15 subfamily among the hS100 proteins (Figure 1b) . In contrast, genomic and phylogenetic human-mouse comparisons for other S100 members showed a single match (Figure 1a and b). Based on the multiple protein sequence comparison used to generate the phylogenetic tree, there is a lower degree of identity (31%) between the mS100A15 and its best human match (S100A15) than there is between the other mS100 genes and their human orthologs (average 84%, with a range of 53-97%).
Characterization of the mS100A15 antibody 3961
To generate specific antibodies, we immunized rabbits with a peptide specific for the S100A15 C-terminal sequence.
Western blot analysis of the peptide-purified antibody 3961 stained a low molecular weight band in keratinocyte lysates at about the level of the recombinant monomer protein (Figure 2a and b arrow), whereas related recombinant S100 proteins were not detected. Several higher molecular bands represent uncleaved fusion protein in the recombinant mS100A15 lane. Longer exposure of the membrane added a ladder of highmolecular weight bands in the lysate (Figure 2b, asterisk) . Staining of proteins pulled down with the mS100A15 antibody revealed a number of faint high molecular weight bands (data not shown), and a main low molecular band (monomer) at low exposure (Figure 2c ). Both, the low and high molecular bands were blocked by increasing molar concentrations of the S100A15-specific peptide (Figure 2b) . Accordingly, the epidermal staining of newborn skin diminished when the antibody was preincubated with blocking peptide as demonstrated by immunohistochemistry (Figure 2d ).
Regulation and crosslinking of mS100A15 during epidermal maturation
To investigate the distribution of the S100A15 in skin, we analyzed newborn mouse skin by immunostaining. In newborn skin, mS100A15 was localized in the differentiated layers of the interfollicular epidermis and hair follicles ( Figure  2d ). In the dermis, the muscularis mucosae layer stained mS100A15 positive. Immunofluorescence double staining with markers of basal cells (Keratin 5) and spinous cells (Keratin 10) indicated S100A15 is localized to the epidermal granular and cornified layers (Figure 3a and b) and to the maturing cells of the hair follicle.
To confirm the mS100A15 distribution, dissociated newborn mouse skin keratinocytes were density separated into their compartments based on buoyancy in Percol. Dense basal cell and buoyant differentiated cells (Figure 3c and d) were isolated and lysates subjected to immunoblotting. mS100A15 was mainly found in the differentiated cell population (Figure 3e , dp, ds). Interestingly, the mS100A15 monomer was detected in the detergent-soluble fraction (ds, arrow) of differentiated keratinocytes (Figure 3d ), whereas immunoreactive high molecular weight complexes were found among the corresponding detergent-insoluble fraction (dp, asterisk) after solubilization with SDS. Furthermore, identical migratory high molecular weight bands reacted with an antibody for transglutaminase-mediated protein crosslinks concordant with potential tranglutaminase-reactive sites within the mS100A15 protein sequence.
In cultured keratinocytes, stimulation of transglutaminase activity by calcium led to an increase of mS100A15 immunoreactive high molecular weight protein complexes (Figure 4a and b, lanes 1 and 2), which were also recognized by the antibody for transglutaminase-mediated protein crosslinks as used before (data not shown, compare Figure 3e ). The intensities of these high molecular bands attenuated when co-treated with calcium and a competitive transglutaminase inhibitor (HPB-2) in favor of the mS100A15 monomer ( Figure  4a and b, lane 3) .
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Regulation of mS100A15 transcripts during epidermal differentiation in vitro
To characterize the S100A15 regulation during epidermal maturation, murine keratinocytes were induced to differentiate by elevating extracellular calcium. In this model at 0.12 mM calcium, mS100A15 is time-and dose-dependently upregulated and temporally induced with the late differentiation marker loricrin ( Figure 5 ). At higher calcium of 1.2 mM, induction is more rapid as has also been reported for differentiation markers (Yuspa et al., 1989) . The calciummediated induction of mS100A15 transcripts can be blocked by inhibition of protein kinase C (PKC) activity, a known downstream signaling pathway in epidermal differentiation ( Figure 6a , left panel; Denning et al., 1995) .
Phorbol esters also induce epidermal maturation through direct activation of PKC. Similar to calcium, the PKC activator 12-O-tetradecanoylphorbol-13-acetate (TPA) induced mS100A15 expression, and this was also blocked by the PKC inhibitor Gö 6976 (Figure 6a , right panel). The induction of mS100A15 by direct PKC activation was more rapid than calcium-mediated induction and was dependent on TPA dose (Figure 6b ). PKCa is a major isoform regulating expression of late epidermal differentiation markers, and we have generated transgenic mice with K5-targeted expression of this PKC 148,779,369 S100A10 S100A11 S100A9 S100A12 S100A8 S100A7a/S100A15 S100A7c/S100A7 S100A7d S100A7b S100A15 S100A6 S100A5 S100A4 S100A3 S100A2 S100A16 S100A14 S100A13 S100A1
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Epidermal differentiation genes The tree was constructed via a neighbor-joining method and the results of the bootstrap confidence levels of reliability (1,000 repetitions) are indicated at each node. In this tree mouse and hS100 orthologs cluster together, and we note that the paralogs within the hS100A7/A15 subfamily cluster with its single mS100A15 ortholog. At the time when gene duplication in human was reported, S100A7 was the only paralog known, and the gene duplicates had subsequently been named S100A7a-e (Kulski et al., 2003) . Apart from the identified human paralogs S100A15 (S100A7a) and S100A7 (S100A7c), S100A7b is predicted to be coding and was also included in the analysis. According to HUGO guidelines, paralogs should not be designated as ''-like genes'', therefore the recently suggested ''S100A7-like'' nomenclature for the hS100A7/A15 paralogs is not included (Marenholz et al., 2004). isoform to the epidermis (Denning et al., 1995; Cataisson et al., 2003b) . When K5-PKCa keratinocytes were isolated and cultured, baseline expression of mS100A15 was elevated ( Figure 6c ). Furthermore, elevating calcium in these cultures substantially accelerated and enhanced the expression of the mS100A15 compared with FVB/N (FVB) controls. Similarly, direct activation of PKC by TPA amplified transcription of mS100A15 in PKCa transgenic keratinocytes and sustained the expression time ( Figure 6d ). The two major transcription factor pathways activator protein-1 (AP-1) and NF-kB play an important part in regulating keratinocyte maturation, and both are also regulated by PKCa (Cataisson et al., 2003a; Banno et al., 2005; Cataisson et al., 2005) . Inhibition of the NF-kB signaling pathway by transduction of keratinocytes with IkBa super-repressor (IkBasr) adenovirus did not effect either the calcium-or TPA-mediated mS100A15 induction in these cells (Figure 6e and f) . In contrast, introduction of an AP-1 dominant-negative molecule (A-FOS) by adenoviral transduction-abolished basal and both calcium-and TPA-induced mS100A15 levels. Collectively, these results identify mS100A15 as a transcriptional target downstream of PKCa in differentiating keratinocytes consistent with AP-1-dependent regulation of other S100 proteins reported previously (Gebhardt et al., 2002) . Figure 3. Distribution and characterization of mS100A15 within the epidermis stained with the mS100A15 antibody 3961. (a, b) Newborn mouse skin was fixed, processed, and costained with the S100A15 antibody 3961 (red) and (a) Keratin 5 (green) or (b) Keratin 10 (green), the nuclei were stained with DAPI (blue). (c-f) Keratinocytes of the epidermal layers of newborn mouse skin were separated by density centrifugation. The lysate (b) of basal/ spinous keratinocyte fraction (c) and the soluble (ds) and dissolved pelleted fraction (dp) of the differentiated keratinocytes (d) were separated on a denaturing 12% polyacrylamide gel, transferred to nitrocellulose, and incubated (e) with peptide-purified mS100A15 antibody 3961 (1 mg/ml) or an antibody recognizing transglutaminase-mediated protein crosslinks (1:500). The arrow indicates the migration of the S100A15 monomer; higher molecular weight-immunoreactive complexes are indicated by the asterisk. 
DISCUSSION
This study characterizes the mS100A15 as an ortholog of the hS100A7/A15 subfamily. The results indicate striking similarities with their human counterparts in genomic organization, protein sequence, expression, distribution, and regulation during normal epidermal maturation, validating functional studies utilizing the mouse model. Phylogenetic analysis assigned most members of the mS100 family to its single human counterpart, whereas the mS100A15 clustered with the group of the hS100 members indicating this mouse gene is likely to be close to the ancestral gene for all of these paralogs (S100A7/A15 subfamily; Figure 1b) . Consistent with these findings, both experimental Southern blot analysis ( Figure S2 ) and computational genomic Blast analysis (Figure 1a) indicate only a single genomic copy exists in mice. Primate and rodent evolution has split after the appearance of the insectivores (Li and Graur, 1991 , and references therein). Thus, the mS100A15 and its human paralogs represent successors from a yet to be identified ancestor organism. Therefore, the exact ancestral lineage of the hS100A7/A15 family members may not be found from mouse-human genomic comparisons alone. Also, since the S100A7/15 region undergoes chromosomal rearrangements and gene duplications, the otherwise phylogenetic conserved gene orientation may not be useful for determining the primordial member of the S100A7/15 family ( Figure 1a ; Kulski et al., 2003; Marenholz et al., 2004) . However, the single gene copy in mouse suggests that the murine gene is closer to this particular ancestor than each of the human paralogs that derived later during primate evolution (Kulski et al., 2003) . Hence, the mouse gene could represent characteristics common to all of its human successors.
In human, a total of five genomic S100A7/A15-like copies have evolved, of which three are predicted to be functional (Kulski et al., 2003) . Expression of two of the three has been described (S100A7, S100A15; Madsen et al., 1991; Wolf et al., 2003) . For the mouse ortholog, aa analysis predicted an N-terminal calcium-binding motif, which is also found in the hS100A15 but not in the hS100A7 (Wolf et al., 2003) . In contrast, a full Jab-1-binding motif is predicted for both the mouse ancestor and the hS100A7 but not for the hS100A15 (Webb et al., 2005) . Phylogenetic analyses showed the mouse ancestor to be most related to S100A7 and S100A15 among the human paralogs (Figure 1b) . However, the slightly better alignment between the mouse gene and the hS100A15 might have favored the re-annotation of the mouse gene ''S100A7 like'' (XM_143311) to ''S100A15 like'' (XM_356221) by National Center for Biotechnology Information. Accordingly, we refer the mouse ortholog as in S100A15 (AY465109, NM_199422).
To produce polyclonal antibodies, we immunized rabbits with a mS100A15-specific peptide. Proving specificity, the resulting peptide-purified antibody 3961 detected the recombinant S100A15 protein, but not related S100 proteins. Further, antibody competition with the corresponding peptide blocked the recognition of the mS100A15 protein in both immunoblot analysis and immunohistochemistry (Figure 2b and d). Staining of keratinocyte lysate showed a corresponding low molecular weight band, which, however, appeared slightly higher than that of the recombinant mS100A15 (Figure 2a ). Post-translational modifications, particularly intramolecular crosslinking by disulfide bonds, can retard the gel separation of S100 proteins, suggesting that these could also have occurred in mS100A15 monomers (Figure S1b: cysteine 6, 74, 88, 98, 102 ) when natively expressed in keratinocytes (Calissano et al., 1976) . Furthermore, crosslinking of S100 monomers to themselves or others can lead to the formation of multimers (Ruse et al., 2001; Broome et al., 2003) . Keratinocyte lysate also stained for mS100A15-positive multimers, which could be competed by the immunizing peptide, indicating the presence of mS100A15.
High molecular weight protein complexes are assembled by transglutaminase-mediated crosslinking to participate in the cornified envelope of differentiated layers of the human and mouse epidermis (Hennings et al., 1980; Eckert et al., 2005) . Potential transglutaminase-reactive residues are predicted in the mS100A15 protein sequence ( Figure S1b ; Birckbichler and Patterson, 1980) . Analysis of isolated differentiated keratinocytes reveals detergent-insoluble mS100A15-positive multimers that were also recognized by an antibody for transglutaminase-mediated protein crosslinks (Figure 3) . In cultured keratinocytes, mS100A15 high molecular weight complexes form during differentiation simulated by calcium switch (Figure 4) . The induced S100A15 multimer formation could be attenuated by using a substrate-competitive transglutaminase inhibitor, and the simultaneous increase of the mS100A15 monomer further indicates that the protein is a transglutaminase substrate. Together, our data show that these multimers are likely to form by covalent attachment of the mS100A15 monomer to other proteins by transglutaminase. Heteromultimers, formed by transglutaminase, have been reported for the hS100A7 and high molecular weight complexes were also detected for the hS100A15 (unpublished data), suggesting that this characteristic is shared among the mouse and human orthologs (Ruse et al., 2001) . mS100A15-containing multimers were mainly detected in isolated differentiated keratinocytes and antibody staining localized the protein to the differentiating compartment in skin sections (Figure 3 ), indicating these high molecular weight complexes contribute to the suprabasal granular and cornified layers (Figure 2 ). mS100A15 staining is also detected in differentiating cells of the hair follicles, a location also positive in human skin stained with some of the antibodies against hS100A7 (Martinsson et al., 2005) . The expression of the mS100A15 in skin maturation could be mirrored in keratinocytes that are induced to differentiate by elevating extracellular calcium ( Figure 5 ). The mS100A15 coregulation with late differentiation markers is in accordance with the in situ staining pattern above Keratins 5 and 10 in the newborn skin (compare Figure 3a and b) . Calcium-mediated signal transduction is highly complex in epidermal differentiation and can involve the activation of protein kinases C (PKC; Denning et al., 1995; Lee et al., 1997; Bikle et al., 2001) . Inhibition of PKC activity diminished the calciuminduced mS100A15 expression, suggesting that PKC participates in that regulation of mS100A15 (Figure 6b ). This is . Regulation of mS100A15 transcripts by calcium and TPA is PKCa regulated and depends on AP-1 activity. Relative mS100A15 transcript levels are plotted. Graphs represent results from two to five independent experiments performed in duplicates to triplicates. Error bars, SEM; *Po0.05, **Po0.001, Student's t-test versus contol. Newborn murine keratinocytes were treated (a) with 0.1% DMSO and with 1.2 mM calcium for 24 hours or 5 ng/ml TPA for 3 hours as indicated. When used, PKC inhibitor Gö 6976 (5 mM) is added 30 minutes before addition of test substance. (b) Cells were treated with TPA for the indicated doses and time intervals. Newborn murine keratinocytes (WT) and K5-PKCa transgenic keratinocytes (K5-PKCa) were treated (c) with calcium for 24 hours or (d) TPA for 3 hours. K5-PKCa transgenic keratinocytes were treated with (e) calcium for 24 hours or (f) TPA for 3 hours after transduction with adenoviral A-cytomegalovirus (control), AP-1 dominant-negative (A-FOS), or IkBa super-repressor constructs (IkBasr), respectively. In parallel, AP-1-and NF-kB-regulated genes have been used to validate the efficacy of the corresponding constructs (data not shown).
www.jidonline.org 1605 further supported by induction of mS100A15 with direct PKC activation by TPA paralleling the calcium effect (Figures 5  and 6b ). However, particularly the calcium-stimulated mS100A15 expression was not fully blocked by PKC inhibition, suggesting that pathways other than PKC might be involved. Several PKC isoforms are involved in keratinocyte maturation in which activation of the calcium-sensitive PKCa is shown to regulate late differentiation marker expression in an AP-1-dependent manner (Dlugosz and Yuspa, 1994; Rutberg et al., 1996; Yang et al., 2003) . Compared with normal keratinocytes, the enhanced transcription of S100A15 in calcium-and TPA-stimulated PKCa transgenic keratinocytes (Figure 6c and d) indicates a PKCa-mediated regulation of the mS100A15. Furthermore, induction by elevated calcium or TPA requires AP-1 transcriptional activation but is independent of NF-kB (Figure 6e and f) . This regulation pattern is concordant with expression and distribution of the mS100A15 in differentiated layers of normal skin. In addition, the localization and regulation of mS100A15 high molecular weight forms is also consistent with PKC-and AP1-dependent transglutaminase activity in differentiated keratinocytes (Dlugosz and Yuspa, 1994; Eckert and Welter, 1996) . Thus, both expression and processing are concordant functions during keratinocyte maturation. In human, both known counterparts, S100A7 and S100A15, are found upregulated with disturbed calcium homeostasis and premature late differentiation (psoriasis); however, underlying regulatory mechanisms are under investigation (Madsen et al., 1991; Wolf et al., 2003; Martinsson et al., 2005) . Pathways regulating S100A15 in mice could help to elucidate the regulation and role of the hS100A7/A15 paralogs in normal skin and disease. The results presented in this study confirm that the mS100A15 represents the murine ortholog of the hS100A7/A15 subfamily. This conclusion is supported by comparing genomic organization and protein similarity across the species for phylogenetic relationship. Furthermore, expression, distribution and regulation as well as post-translational crosslinking of the mS100A15 by transglutaminase during normal epidermal maturation are additional common features shared with its human counterparts. Concordant with the assumed role for its human successors in normal and disturbed epidermal maturation, we conclude that the mS100A15 can be used to study the role of the S100A7/A15 family in hyperplastic and other cutaneous diseases using the mouse model.
MATERIALS AND METHODS
All the Materials and Methods used have been approved by the National Cancer Institute.
Synthesis, cloning, and sequence analysis of the mS100A15 cDNA
Freshly dissected mouse tissues were snap frozen in liquid nitrogen and homogenized in TRIZOL s reagent (Invitrogen, Karlsruhe, Germany) using a dismembrator (Braun, Melsungen, Germany).
Total RNA (1 mg) was denaturated at 701C for 10 minutes and first-strand cDNA was synthesized in a 20 ml reaction solution containing 4 ml 5 Â reverse transcription buffer (Invitrogen), 25 ng/ml oligo-dT primers, 0.5 mM dNTPs, 10 mM dithiothreitol, 40 U RNasin (Promega, Mannheim, Germany) and 200 U Superscript III-Reverse Transcriptase (Invitrogen) at 501C for 1 hour and 601C for 10 minutes.
PCR reactions (20 ml) contained 1 ml of the reverse transcription sample, 2 ml 10 Â buffer (Qiagen, Hilden, Germany), 1.5 mM MgCl 2 , 0.2 mM dNTPs, diethyl pyrocarbonate-treated water, 2 U Taq polymerase (Qiagen), and 0.1 mM of specific intron spanning primer pairs. For amplification of the mS100A15 transcripts, primers were based on the genomic sequence deposited in GenBank (clone RP1-128L15, accession no.: AL591704): S100A15 -sense, exon 1: 5 0 -ATCTCACTCATCCTTCTACTCGTG-3 0 ; S100A15 -antisense, exon 3: 5 0 -GAGCTAAGAGAGAAAGAGAGCAA-3 0 .
The PCR conditions were 31 cycles at 941C for 1 minute, 561C for 1 minute, and 721C for 1 minute ( þ time increment of 2 seconds/ cycle) followed by an additional extension step at 721C for 5 minutes. PCR products were separated on a 1.5% agarose gel, extracted (QiaexII; Qiagen) and cloned into pCRII-TOPO (Invitrogen). Insert-containing plasmids were purified from transformed E. coli Top10 cells (Invitrogen) using QIAprep-spin columns (Qiagen) and sequenced with flanking M13-sequencing primers.
Southern blotting
Genomic mouse DNA was digested by restriction enzymes as described in the individual experiment. Digested DNA per lane (10 mg) was fractionated on a 1% agarose gel and transferred onto a Hybond-N þ membrane (Amersham, Braunschweig, Germany). The mS100A15 probe was generated by PCR under conditions described above. The PCR fragments were radioactively labeled with the High Prime DNA Labeling Kit s (Roche, Mannheim, Germany) and hybridized in DIG Easy hyb solution s (Roche) at 371C. The autoradiographic signals were analyzed with a phosphoimager (ImageQuant, Molecular dynamics, Heidelberg, Germany).
Cell culture and adenovirus transduction
Epidermal cells from newborn FVB/N mice were isolated and cultured in Eagle's medium with 8% fetal calf serum, 1% antibiotic, and a calcium concentration of 0.05 mM as described . After 7 days, primary cultures were switched to medium with various calcium, or TPA concentrations as indicated, and transglutaminase substrate inhibitor HPB-2 (syn. RS 71666, similar to RS 10823; Killackey et al., 1989) . When used, transglutaminase inhibitor was added 24 hours before calcium switch. Keratinocytes were harvested into lysis buffer for protein analysis (Cell Signaling, Beverly, MA) by SDS-PAGE and for RNA analysis (Quiagen, Valencia, CA) by semiquantitative reverse transcription-PCR. For certain experiments, the IkBasr (Guttridge et al., 1999) or A-FOS (Olive et al., 1997; Bonovich et al., 2002) adenoviruses were introduced into primary keratinocytes using an adenoviral construct driven by a cytomegalovirus promoter and empty adenovirus was used as control (A-cytomegalovirus). The cells were infected for 30 minutes in serum-free medium with a multiplicity of infection of five viral particles/cell and 2.5 mg/ml of Polybrene (Sigma, St Louis, MO) to enhance uptake. Serum-containing medium was added to the cells for the next 24 hours after the infection.
Semiquantitative PCR analysis
RNA was isolated from cultured cells (RNeasy, Qiagen) according to the manufacturer's instructions and reverse transcribed using Superscript III. Transcript levels of mS100A15, Keratins 5 and 10, loricrin (Roop et al., 1983) and 18S control (Ambion, Woodward, TX) were optimized to the log-linear phase of the PCR amplification for each set of primers. Quantification of fragments was based on two different cycles within the log-linear phase. Amplicons were subjected to agarose-gel electrophoresis (2%) and stained with ethidium bromide. The density of the amplicons was measured by integrating UV light of the stained bands using a digital camera image analyzing system (Multianalyst, Biorad Laboratories, Hercules, CA), and expressed as the relative signal intensity normalized by 18S expression (relative intensity). mS100A15 antibody production, immunoprecipitation, immunoblot analysis, and immunohistochemistry Monospecific antisera to mS100A15 were prepared in rabbits by injecting a synthetic peptide that corresponds to the carboxyterminal aa sequence of the deduced S100A15 protein (GenBank accession no.: NP_955454). The rabbit antibodies were affinity purified using the synthetic peptide coupled to Affigel-ISC (Biorad) (Goldsmith et al., 1987) . Primary mouse keratinocyte lysate was immunoprecipitated with the S100A15 antibody 3961 using Seize X protein A immunoprecipitated Kit s (Pierce, Rockford, IL). Immunoprecipitated beads were consecutively eluted, separated and analyzed with the same antibody. Recombinant proteins were generously provided by Philippe Tessier (Laval University, Quebec, Canada; Vandal et al., 2003) .
For immunoblot analysis, cultures were washed twice with PBS, and total cell lysates prepared using 1% Triton-containing lysis buffer (Cell Signalling). For some experiments, dissociated newborn mouse keratinocytes were prepared and density separated in Percol as described previously (Fischer et al., 1982) . Upon centrifugation, insoluble protein fractions were dissolved with an SDS containing lysis buffer (5% SDS, 20% b-mercaptoethanol in 0.25 M Tris, pH 6.8; Yuspa et al., 1989) . Proteins were separated using a 12% polyacrylamide gel, transferred to reinforced nitrocellulose membrane and visualized by Ponceau stain. Filters were incubated with blocking buffer (TBS, pH 7.4, with 5% milk, 0.1% Tween 20) for 30 minutes, primary antibody (anti-S100A15 3961, 1 mg/ml; anti-Ne g-glutamyl lysine, 1:500; Abcam, Cambridge, MA; anti-b actin, 1:20,000; Chemicon, Temecula, CA) overnight, and secondary antibody for 1 hour with several washes (TBS, pH 7.4, 0.1% Tween 20) between the incubations.
Immunohistochemistry was performed on serial 5 mm frozen sections of skin from newborn FVB mice, fixed in acetone. The sections were treated with 96% methanol and 4% hydrogen peroxide to inhibit peroxidase activity, blocked in 10% normal goat serum, and incubated overnight with mS100A15 3961 rabbitderived polyclonal antibody (5 mg/ml). Slides were then treated the next day with biotinylated anti-rabbit IgG (H þ L) (1:1,000), followed by an avidin-biotin complex incubation (Elite Vectastain). Samples were exposed using the Vector DAB Kit and mounted with mounting medium. All reagents for immunostaining were from Vector Laboratories, Burlington, CA. Serial dilution competition assays were performed in the absence and presence of blocking peptide as indicated to determine the optimal working concentration and specificity of the primary mS100A15 antibody using both immunohistochemistry and immunoblot analysis.
For immunoflourescence, goat anti-rabbit Cy3 was used as a secondary antibody to the mS100A15 3961 (Jackson Laboratory, Bar Harbor, MI). If the sections were to be co-stained, Keratin 5-FITC and Keratin 10-FITC were used (Covance, Richmond, CA). All sections were nuclear stained with 4,6-diamidino-2-phenylindole (Sigma) and mounted with mounting medium for immunofluorescence.
Bioinformatics
Genomic introns/exon structures were predicted using DIGIT, Genescan, HMMgene, and NetGene2. Webcutter version 2 software was used for identification of recognition sites for DNA restriction enzymes within a 15,749 nt region flanking the mS100A15 gene (NT_039234.3, nt 26, 112, 128, 174) . The ExPASy nucleotide translation tool (Swiss Institute of Bioinformatics, Switzerland; http:// www.expasy.org/tools/dna.html) was used to translate cDNA in all six open reading frames. For prediction of the protein consensus pattern, profiles, structures, and potential post-translational modification, InterPro Scan, Hits, 3D-PSSM, and PSIPred were used, available from Swiss Institute of Bioinformatics. The PromoterInspector (Genomatix, Munich, Germany) was used for prediction of transcription factor binding sites and typical promoters.
The aa sequences of the S100 families from mouse and human were aligned using the program Tcoffee (version 2.11; Poirot et al., 2004) . The phylogenetic tree was constructed using ClustalW's (version 1.81; Thompson et al., 1994) Neighbor-joining method with gap exclusion (Saitou and Nei, 1987) . The reliability of the phylogeny's interior branches was tested by performing the bootstrap method with 1,000 replications. The sequences used are listed in Supplementary Material.
